Clinical Trial Update: Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease [Phase 1]

View source ↗

Summary

A Phase 1 PET brain occupancy study in healthy volunteers assessed a PDE4 inhibitor. Huntington's disease was listed as the condition, and the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• PDE4 inhibitor (PDE4 inhibitor)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Huntington Disease | Phase 1 | Status: COMPLETED